Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for GNGBF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 2005. Start Trial.
Date Value
July 31, 2026 65.97%
June 30, 2026 65.97%
May 31, 2026 65.97%
April 30, 2026 65.97%
March 31, 2026 65.97%
February 28, 2026 65.97%
January 31, 2026 65.97%
December 31, 2025 65.97%
November 30, 2025 65.97%
October 31, 2025 65.97%
September 30, 2025 65.97%
August 31, 2025 65.97%
July 31, 2025 65.97%
June 30, 2025 65.97%
May 31, 2025 65.97%
April 30, 2025 65.97%
March 31, 2025 65.97%
February 28, 2025 65.97%
January 31, 2025 65.97%
December 31, 2024 65.97%
November 30, 2024 65.97%
October 31, 2024 65.97%
September 30, 2024 65.97%
August 31, 2024 65.97%
July 31, 2024 65.97%
Date Value
June 30, 2024 65.97%
May 31, 2024 65.97%
April 30, 2024 65.97%
March 31, 2024 65.97%
February 29, 2024 65.97%
January 31, 2024 66.27%
December 31, 2023 72.94%
November 30, 2023 72.94%
October 31, 2023 72.94%
September 30, 2023 72.94%
August 31, 2023 72.94%
July 31, 2023 72.94%
June 30, 2023 74.51%
May 31, 2023 74.51%
April 30, 2023 74.51%
March 31, 2023 74.51%
February 28, 2023 74.51%
January 31, 2023 74.51%
December 31, 2022 74.51%
November 30, 2022 74.51%
October 31, 2022 74.51%
September 30, 2022 74.51%
August 31, 2022 74.51%
July 31, 2022 74.51%
June 30, 2022 74.51%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Xvivo Perfusion AB 78.31%
Paxman AB 61.64%
Enovis Corp. 77.93%
Edwards Lifesciences Corp. 54.32%
Intuitive Surgical, Inc. 49.90%